City of Hope at BIO Convention 2025
City of Hope®, a world-renowned, National Cancer Institute-designated comprehensive cancer center, has one of the largest geographic footprints in cancer research and treatment, with 40 clinical network locations across the United States. With more than 730 clinical trials enrolling more than 5,900 patients each year, we are more committed than ever to unlocking groundbreaking discoveries to improve outcomes for all types of cancer.
A leader in cellular immunotherapies, City of Hope is also home to one of the most comprehensive chimeric antigen receptor (CAR) T cell therapy programs in the world, with over 1,200 patients treated in immune effector cell trials — part of a robust clinical trial program that spans both hematologic malignancies and solid tumors.
Translational Genomics Research Institute (TGen), part of City of Hope, is a genomic-based biomedical research organization that has led the field of precision medicine and the use of genomic information in support of treatment decisions and improved patient outcomes. Our scientists and doctors innovate daily through research in the areas of cancer, metabolic and neurological-related diseases, pathogen and microbiome research and rare childhood disorders.
We’re reaching a wider, more diverse population of patients with our national system of cancer centers and outpatient locations, from California and Arizona to Illinois and Georgia, expanding access, expertise and innovation to people across the country.
Resources
In the global pursuit of scientific miracles in the fight against deadly diseases, the Beckman Research Institute of City of Hope is among those leading the charge. Its world-renowned staff have been responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
City of Hope has joined forces with the TGen to accelerate the speed with which scientists and medical staff convert research discoveries into cures for patients. The alliance is based on a simple premise: City of Hope provides a state-of-the-art clinical setting in which to advance genomic breakthroughs made by TGen.
The GMP Manufacturing Shared Resource (GMP-SR) at City of Hope (COH) offers both biological and chemical GMP manufacturing capabilities allowing for rapid and cost-effective translation of novel therapeutic agents to clinical trials. Together, the biological and chemical GMP facilities are unique to COH and have distinguished it as one of the premier cancer institutions in the nation for translating innovative therapies developed by COH investigators over the past decade.
To facilitate scientific progress, City of Hope and Beckman Research Institute of City of Hope provide investigators and their laboratory teams access to sophisticated support services and state-of-the-art equipment through many of our Shared Resources facilities.
One of the most promising areas of cancer research and treatment is known as immunotherapy, in which a patient’s immune system is enlisted in the fight against cancer. This approach is more than just a narrow field of study at City of Hope. It is the central component of groundbreaking research and clinical trials currently underway.
We’re aggressively pursuing ways to help our patients right now — not years from now. That immediacy of focus makes City of Hope a worldwide leader in administering clinical trials. Each year, we conduct more than 800 clinical trials enrolling more than 5,000 patients.
At City of Hope’s Center for Precision Medicine, our vision is to harness genomic insights, clinical expertise and advanced analytics to pioneer personalized treatment and prevention, improving quality of life for our patients and their families.
City of Hope is a leader in clinical and translational research, most notably in antibody-based therapy, CAR T cell therapy and bone marrow transplant approaches. When you refer your patient to City of Hope, you can feel confident that our staff will provide them with the best care possible.
We’re looking for extraordinary individuals to join our internationally renowned community of physicians, researchers and other health care professionals.